Bradyzoite pseudokinase 1 is crucial for efficient oral infectivity of the Toxoplasma gondii tissue cyst

Eukaryotic Cell

Volumn 12, Issue 3, 2013, Pages 399-410

  Buchholz, Kerry R ^a   Bowyer, Paul W ^a,b   Boothroyd, John C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CYST; FEMALE; GENE DELETION; GENETICS; METABOLISM; MOUSE; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PROTOZOAN SPORE; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALS; CYSTS; FEMALE; GENE DELETION; MICE; MICE, INBRED C57BL; PROTOZOAN PROTEINS; SPORES, PROTOZOAN; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84874545245     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00343-12     Document Type: Article

References (43)

1. Montoya J, Kovacs J, Remington J. 2005. Toxoplasma gondii, p 3170-3197. In Mandell G, Bennett J, Dolin R (ed), Principles and practice of infectious diseases, 6th ed. Elsevier, Philadelphia, PA.
2. Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ, Held T, Cordonnier C. 2000. Toxoplasmosis after hematopoietic stem cell transplantation. Clin. Infect. Dis. 31:1188-1195.
3. Pruitt AA. 2004. Central nervous system infections in cancer patients. Semin. Neurol. 24:435-452.
4. Dubey JP, Lindsay DS, Speer CA. 1998. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11:267-299.
5. Weiss LM, Kim K. 2007. Bradyzoite development, p 341-366. In Weiss LM, Kim K (ed), Toxoplasma gondii. The model apicomplexan: perspectives and methods. Academic Press, London, United Kingdom.
6. Zhang YW, Halonen SK, Ma YF, Wittner M, Weiss LM. 2001. Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein. Infect. Immun. 69:501-507.
7. Craver MP, Rooney PJ, Knoll LJ. 2010. Isolation of Toxoplasma gondii development mutants identifies a potential proteophosphoglycan that enhances cyst wall formation. Mol. Biochem. Parasitol. 169:120-123.
8. Parmley SF, Yang S, Harth G, Sibley LD, Sucharczuk A, Remington JS. 1994. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol. Biochem. Parasitol. 66:283-296.
9. Buchholz KR, Fritz HM, Chen X, Durbin-Johnson B, Rocke DM, Ferguson DJ, Conrad PA, Boothroyd JC. 2011. Identification of tissue cyst wall components by transcriptome analysis of in vivo and in vitro Toxoplasma gondii bradyzoites. Eukaryot. Cell 10:1637-1647.
10. Hanks SK, Hunter T. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-596.
11. Boudeau J, Miranda-Saavedra D, Barton GJ, Alessi DR. 2006. Emerging roles of pseudokinases. Trends Cell Biol. 16:443-452.
12. Fux B, Nawas J, Khan A, Gill DB, Su C, Sibley LD. 2007. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect. Immun. 75:2580-2590.
13. Ong YC, Reese ML, Boothroyd JC. 2010. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J. Biol. Chem. 285:28731-28740.
14. Soldati D, Boothroyd JC. 1993. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science 260:349-352.
15. Kim SK, Karasov A, Boothroyd JC. 2007. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect. Immun. 75:1626-1634.
16. Donald RG, Carter D, Ullman B, Roos DS. 1996. Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation. J. Biol. Chem. 271:14010-14019.
17. Reese ML, Boothroyd JC. 2009. A helical membrane-binding domain targets the Toxoplasma ROP2 family to the parasitophorous vacuole. Traffic 10:1458-1470.
18. Dix MM, Simon GM, Cravatt BF. 2008. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 134:679-691.
19. Bowyer PW, Simon GM, Cravatt BF, Bogyo M. 2011. Global profiling of proteolysis during rupture of Plasmodium falciparum from the host erythrocyte. Mol. Cell. Proteomics 10:M110.001636. doi:10.1074/mcp.M110.001636.
20. Fritz HM, Bowyer PW, Bogyo M, Conrad PA, Boothroyd JC. 2012. Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One 7:e29955. doi:10.1371/journal.pone.0029955.
21. Tabb DL, McDonald WH, Yates JR, III. 2002. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1:21-26.
22. Adjogble KD, Mercier C, Dubremetz JF, Hucke C, Mackenzie CR, Cesbron-Delauw MF, Daubener W. 2004. GRA9, a new Toxoplasma gondii dense granule protein associated with the intravacuolar network of tubular membranes. Int. J. Parasitol. 34:1255-1264.
23. Carey KL, Donahue CG, Ward GE. 2000. Identification and molecular characterization of GRA8, a novel, proline-rich, dense granule protein of Toxoplasma gondii. Mol. Biochem. Parasitol. 105:25-37.
24. Saeij JP, Arrizabalaga G, Boothroyd JC. 2008. A cluster of four surface antigen genes specifically expressed in bradyzoites, SAG2CDXY, plays an important role in Toxoplasma gondii persistence. Infect. Immun. 76:2402-2410.
25. Dunn JD, Ravindran S, Kim SK, Boothroyd JC. 2008. The Toxoplasma gondii dense granule protein GRA7 is phosphorylated upon invasion and forms an unexpected association with the rhoptry proteins ROP2 and ROP4. Infect. Immun. 76:5853-5861.
26. Brymora A, Valova VA, Robinson PJ. 2004. Protein-protein interactions identified by pull-down experiments and mass spectrometry. Curr. Protoc. Cell Biol. Chapter 17, Unit 17.5. doi:10.1002/0471143030.cb1705s22.
27. Huskinson-Mark J, Araujo FG, Remington JS. 1991. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J. Infect. Dis. 164: 170-171.
28. Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, Carson MJ, Wilson EH. 2010. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect. Immun. 78:2257-2263.
29. Dzierszinski F, Nishi M, Ouko L, Roos DS. 2004. Dynamics of Toxoplasma gondii differentiation. Eukaryot. Cell 3:992-1003.
30. Hager KM, Striepen B, Tilney LG, Roos DS. 1999. The nuclear envelope serves as an intermediary between the ER and Golgi complex in the intracellular parasite Toxoplasma gondii. J. Cell Sci. 112(Part 16):2631-2638.
31. Kawase O, Nishikawa Y, Bannai H, Igarashi M, Matsuo T, Xuan X. 2010. Characterization of a novel thrombospondin-related protein in Toxoplasma gondii. Parasitol. Int. 59:211-216.
32. Huynh MH, Carruthers VB. 2009. Tagging of endogenous genes in a Toxoplasma gondii strain lacking Ku80. Eukaryot. Cell 8:530-539.
33. Jacobs D, Dubremetz JF, Loyens A, Bosman F, Saman E. 1998. Identification and heterologous expression of a new dense granule protein (GRA7) from Toxoplasma gondii. Mol. Biochem. Parasitol. 91:237-249.
34. Friedrich N, Santos JM, Liu Y, Palma AS, Leon E, Saouros S, Kiso M, Blackman MJ, Matthews S, Feizi T, Soldati-Favre D. 2010. Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites. J. Biol. Chem. 285:2064-2076.
35. Fritz HM, Buchholz KR, Chen X, Durbin-Johnson B, Rocke DM, Conrad PA, Boothroyd JC. 2012. Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. PLoS One 7:e29998. doi:10.1371/journal.pone.0029998.
36. Fleckenstein MC, Reese ML, Konen-Waisman S, Boothroyd JC, Howard JC, Steinfeldt T. 2012. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol. 10:e1001358. doi:10.1371/journal.pbio.1001358.
37. Fox BA, Falla A, Rommereim LM, Tomita T, Gigley JP, Mercier C, Cesbron-Delauw MF, Weiss LM, Bzik DJ. 2011. Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot. Cell 10:1193-1206.
38. Zhang YW, Kim K, Ma YF, Wittner M, Tanowitz HB, Weiss LM. 1999. Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation. Mol. Microbiol. 31:691-701.
39. Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, Remington JS, McLeod R. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428.
40. Schwarz JA, Fouts AE, Cummings CA, Ferguson DJ, Boothroyd JC. 2005. A novel rhoptry protein in Toxoplasma gondii bradyzoites and merozoites. Mol. Biochem. Parasitol. 144:159-166.
41. Boyle JP, Saeij JP, Boothroyd JC. 2007. Toxoplasma gondii: inconsistent dissemination patterns following oral infection in mice. Exp. Parasitol. 116:302-305.
42. Lavine MD, Knoll LJ, Rooney PJ, Arrizabalaga G. 2007. A Toxoplasma gondii mutant defective in responding to calcium fluxes shows reduced in vivo pathogenicity. Mol. Biochem. Parasitol. 155:113-122.
43. Garrison E, Treeck M, Ehret E, Butz H, Garbuz T, Oswald BP, Settles M, Boothroyd J, Arrizabalaga G. 2012. A forward genetic screen reveals that calcium-dependent protein kinase 3 regulates egress in Toxoplasma. PLoS Pathog. 8:e1003049. doi:10.1371/journal.ppat.1003049.